Sertraline HCL Tablets

The opportunity is for the supply of Sertraline HCL Tablets in various count bottles. The contract has already been awarded to Exelan Pharmaceuticals Inc. with an award amount of $24,078,212.33 and an award date of June 28, 2021. The place of performance is in New York, USA. Key aspects of the job include the supply of pharmaceuticals, specifically Sertraline HCL Tablets, in different strengths and packaging counts. • The contract involves the supply of Sertraline HCL Tablets in 25MG, 50MG, and other strengths. • The tablets are to be supplied in bottles of various counts, including 30, 90, 180, and 500. • The contract has an option to extend the term, as indicated by the exercise of Option 2. • The primary point of contact for this opportunity is Keith Ryales, although his role and phone number are not specified in the provided text.